Author Guest Post With Allen Wyler

Allen Wyler has kindly agreed to guest post here about his work, and share his inspiration for becoming a writer in honor of his medical thriller, Dead End Deal.
 About The Author:


DEMONSTRATION
Surgical teaching session in Hong Kong
In his first year of medical school, Allen Wyler knew he wanted to specialize in neurosurgery. Upon graduating from residency he started on the faculty of the University of Washington and then the University of Tennessee where he developed an international reputation for pioneering surgical techniques to record brain activity. In 1992 the prestigious Swedish Medical Center recruited him back to Seattle to develop a neuroscience institute.

Wyler’s love of thrillers began in 1974 on his way to Cincinnati to take the oral boards in neurosurgery. At SeaTac airport he picked up a copy of William Goldman’s Marathon Man to read on the flight. He became so engrossed he stayed up all night to finish it before stoking up on coffee and meeting with the examiners. He aced the exam.

Wyler develops plots from actual events in his practice. While serving on a committee charged with selecting the medical center’s new computerized medical record system he wondered what might happen if the software had a random bug. From this came the story line for Deadly Errors, his 2005 thriller that has been subsequently translated into several foreign languages, including Russian.

In 2002 he left active practice to become Medical Director for a start-up medical technology company, Northstar Neuroscience, which went public (NSTR) in 2006. At the end of 2007 he retired to devote full time to writing.

He and his wife divide their time between their downtown Seattle condo and home in the San Juan Islands.

Find Allen Wyler on the Web:

 Guest Post:
HOW DOES ALZHEIMERS RANK AS ONE OF THE MOST PRESSING DISEASES IN THE 21ST CENTURY?  WHY AND IF IT GOES UNCHECKED HOW WILL IT IMPACT OUR SOCIETY?
Chances are you know someone among who either has Alzheimer’s Disease or is directly connected—by relation or care—to someone who has it.  As of this year an estimated 5.4 million Americans are living with AD. That translates to roughly one in eight older Americans.  That’s a staggering number, but yet in the public consciousness, AD isn’t as widely considered (“top of mind”) as the dangerous killer that it is; not like say, cancer or heart failure.  (AD is the sixth leading cause of death in the US).
The fact is, neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease are becoming more prevalent as the average life span of individuals increase and the more common health care problems ARE better treated. It’s predicted that by 2020, thanks to drugs like Lipitor, mortality from heart disease and stroke will be way down, making Alzheimer’s the leading cause of death in our time.  The personal consequences to individuals or families is devastating, but the general consequence to society as a whole is great as well.  That’s because AD patients often live a long time, their care is very expensive and will become a major health issue (both in cost and quality of life) that our society will have to bear.
There is hope in some novel drugs to treat AD. Because the disease results from the build up of Amyloid in nerve cells, a promising approach is to block the production of this protein. In addition, there is intriguing research into the concept of surgically implanting stem cells into especially damaged brain areas.  This possible cure is a central element that I used in the plot for my new novel, Dead End Deal.

Cures and treatments for diseases like AD are very expensive to develop, (millions upon tens of millions of dollars of R&D) with the resulting payoff even greater (billions of dollars of revenue for the “drug” or the “procedure”) often creating entire new branches of medicine, with thousands upon thousands of new jobs.  This high risk / high reward fact of life for medical researchers and practitioners like me is a natural stage for heroes, villains and high-stakes drama.  I try to capture that in my Thrillers, but the true high-stakes drama on the medical treatment/development stage is much more exciting than any fiction; the heroes are by far much more worthy of praise (though they often go unnoticed).  I like to see my books as homage to them, at least in some small way.

  Dead End Deal:

Title: Dead End Deal
Author: Allen Wyler
Publisher: Astor + Blue Editions
Publication Date: March 13, 2012

World renowned neurosurgeon Jon Ritter is on the verge of a medical breakthrough that will change the world. His groundbreaking surgical treatment, using transplanted non-human stem cells, is set to eradicate the scourge of Alzheimer’s disease and give hope to millions. But when the procedure is slated for testing, it all comes to an abrupt and terrifying halt. Ritter’s colleague is gunned down and Ritter himself is threatened by a radical anti-abortion group that not only claims responsibility, but promises more of the same.

Faced with a dangerous reality but determined to succeed, Ritter turns to his long-time colleague, corporate biotech CEO Richard Stillman, for help. Together, they conspire to conduct a clandestine clinical trial in Seoul, Korea. But the danger is more determined, and more lethal, than Ritter could have imagined.

After successful surgical trials, Ritter and his allies are thrown into a horrifying nightmare scenario: The trial patients have been murdered and Ritter is the number one suspect. Aided by his beautiful lab assistant, Yeonhee, Ritter flees the country, now the target of an international manhunt involving Interpol, the FBI, zealous fanatics and a coldly efficient assassin named Fiest.

Find Dead End Deal Online:

Happy reading until next time!